NCT06235853View on ClinicalTrials.gov

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

April 30, 2023

Conditions
Non-muscle Invasive Bladder CancerCystoscopyRecurrenceProgressionBladder CancerBiomarkers
Interventions
DIAGNOSTIC_TEST

Blood serum: sUPAR, PAI-1, IL-8.

The concentration of described biomarkers were measured in serum.

DIAGNOSTIC_TEST

Urine: IL-8, APOE, VEGF.

The concentration of described biomarkers were measured in urine.

Trial Locations (1)

50-367

Wroclaw Medical University, Wroclaw

All Listed Sponsors
lead

Wroclaw Medical University

OTHER

NCT06235853 - Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter